Literature DB >> 10996478

The role of mitochondrial injury in bromobenzene and furosemide induced hepatotoxicity.

S G Wong1, J W Card, W J Racz.   

Abstract

Bromobenzene (BB) and furosemide (FS) are two hepatotoxicants whose bioactivation to reactive intermediates is crucial to the development of liver injury. However, the events which lead to hepatocellular toxicity following metabolite formation and covalent binding to cellular macromolecules remain unknown. The present study was undertaken to investigate the effect of administered BB and FS on mitochondrial total glutathione (GSH+GSSG, henceforth referred to as glutathione) content and respiratory function as potential initiating mechanisms of the hepatotoxicity of these compounds in the mouse. Bromobenzene (2 g/kg i.p.) significantly decreased mitochondrial glutathione to 48% of control at 3 h post administration, and to 41% at 4 h. This decrease in mitochondrial glutathione was subsequent to a significant decrease in cytosolic glutathione to 64 and 28% of control at 1 and 2 h, respectively. Oxygen consumption supported by complex I (glutamate-supported) of the respiratory chain was not inhibited by BB until 4 h, where state 3 (active) respiration was reduced to 16% of control. This resulted in a decreased respiratory control ratio (RCR) for complex I-supported respiration. Complex II (succinate)-supported state 3 and state 4 respiration were unaffected by BB until 4 h, at which time they were reduced to 57 and 48% of control, respectively. However, the similar reductions in state 3 and state 4 respiratory rates did not alter the corresponding RCR for complex II. Overt hepatic injury was detected at 4 h, with plasma alanine aminotransferase (ALT) activity increasing significantly at this time point. In contrast to the effects of BB, FS administration (400 mg/kg i.p.) did not alter mitochondrial or cytosolic glutathione, and had no effect on respiration supported by complex I or II for up to 5 h following dosing. However, ALT activity was significantly increased 5 h following FS administration. These results suggest that inhibition of mitochondrial respiratory function coinciding with a decrease in mitochondrial glutathione content may be crucial to the initiation of BB-induced hepatotoxicity, while such events are not required for the initiation of FS-induced hepatotoxicity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996478     DOI: 10.1016/s0378-4274(00)00218-6

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  14 in total

1.  The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation.

Authors:  Mitchell R McGill; Matthew R Sharpe; C David Williams; Mohammad Taha; Steven C Curry; Hartmut Jaeschke
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

2.  Protective effect of Premna tomentosa extract (L. verbanacae) on acetaminophen-induced mitochondrial dysfunction in rats.

Authors:  K Pandima Devi; M Sreepriya; K Balakrishna; T Devaki
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

3.  Acetaminophen Hepatotoxicity.

Authors:  Anup Ramachandran; Hartmut Jaeschke
Journal:  Semin Liver Dis       Date:  2019-03-08       Impact factor: 6.115

4.  Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome.

Authors:  Mitchell R McGill; Vincent S Staggs; Matthew R Sharpe; William M Lee; Hartmut Jaeschke
Journal:  Hepatology       Date:  2014-08-25       Impact factor: 17.425

5.  Humanized thymidine kinase-NOG mice can be used to identify drugs that cause animal-specific hepatotoxicity: a case study with furosemide.

Authors:  Dan Xu; Sara A Michie; Ming Zheng; Saori Takeda; Manhong Wu; Gary Peltz
Journal:  J Pharmacol Exp Ther       Date:  2015-05-11       Impact factor: 4.030

6.  The role of the c-Jun N-terminal kinases 1/2 and receptor-interacting protein kinase 3 in furosemide-induced liver injury.

Authors:  Mitchell R McGill; Kuo Du; Yuchao Xie; Mary Lynn Bajt; Wen-Xing Ding; Hartmut Jaeschke
Journal:  Xenobiotica       Date:  2014-11-25       Impact factor: 1.908

Review 7.  Biomarkers of drug-induced liver injury.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  Adv Pharmacol       Date:  2019-03-06

Review 8.  Reactive metabolites in the biotransformation of molecules containing a furan ring.

Authors:  Lisa A Peterson
Journal:  Chem Res Toxicol       Date:  2012-10-24       Impact factor: 3.739

9.  Argininosuccinate synthetase as a plasma biomarker of liver injury after acetaminophen overdose in rodents and humans.

Authors:  Mitchell R McGill; Mengde Cao; Archie Svetlov; Matthew R Sharpe; C David Williams; Steven C Curry; Anwar Farhood; Hartmut Jaeschke; Stanislav I Svetlov
Journal:  Biomarkers       Date:  2014-03-06       Impact factor: 2.658

Review 10.  Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-05-16       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.